{"id":"https://openalex.org/W3211348587","doi":"https://doi.org/10.3389/fphar.2021.748740","title":"CXCR7 Antagonism Reduces Acute Lung Injury Pathogenesis","display_name":"CXCR7 Antagonism Reduces Acute Lung Injury Pathogenesis","publication_year":2021,"publication_date":"2021-11-05","ids":{"openalex":"https://openalex.org/W3211348587","doi":"https://doi.org/10.3389/fphar.2021.748740","mag":"3211348587","pmid":"https://pubmed.ncbi.nlm.nih.gov/34803691","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/8602191"},"language":"en","primary_location":{"id":"doi:10.3389/fphar.2021.748740","doi":"https://doi.org/10.3389/fphar.2021.748740","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fphar.2021.748740","pdf_url":null,"source":{"id":"https://openalex.org/S132108250","display_name":"Frontiers in Pharmacology","issn_l":"1663-9812","issn":["1663-9812"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.3389/fphar.2021.748740","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5007988649","display_name":"Laetitia Pouzol","orcid":"https://orcid.org/0000-0001-8727-1142","observed_orcids":["https://orcid.org/0000-0001-8727-1142"]},"institutions":[{"id":"https://openalex.org/I4405257665","display_name":"Idorsia Pharmaceuticals Ltd (Switzerland)","ror":"https://ror.org/05j00sy30","country_code":"CH","type":"company","lineage":["https://openalex.org/I4210136915","https://openalex.org/I4405257665"]}],"countries":["CH"],"is_corresponding":true,"raw_author_name":"Laetitia Pouzol","raw_affiliation_strings":["Idorsia Pharmaceuticals Ltd., Allschwil, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Idorsia Pharmaceuticals Ltd., Allschwil, Switzerland","institution_ids":["https://openalex.org/I4405257665"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057670277","display_name":"Anna Sassi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405257665","display_name":"Idorsia Pharmaceuticals Ltd (Switzerland)","ror":"https://ror.org/05j00sy30","country_code":"CH","type":"company","lineage":["https://openalex.org/I4210136915","https://openalex.org/I4405257665"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Anna Sassi","raw_affiliation_strings":["Idorsia Pharmaceuticals Ltd., Allschwil, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Idorsia Pharmaceuticals Ltd., Allschwil, Switzerland","institution_ids":["https://openalex.org/I4405257665"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5107344285","display_name":"Nad\u00e8ge Baumlin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405257665","display_name":"Idorsia Pharmaceuticals Ltd (Switzerland)","ror":"https://ror.org/05j00sy30","country_code":"CH","type":"company","lineage":["https://openalex.org/I4210136915","https://openalex.org/I4405257665"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Nad\u00e8ge Baumlin","raw_affiliation_strings":["Idorsia Pharmaceuticals Ltd., Allschwil, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Idorsia Pharmaceuticals Ltd., Allschwil, Switzerland","institution_ids":["https://openalex.org/I4405257665"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104009748","display_name":"M\u00e9lanie Tunis","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405257665","display_name":"Idorsia Pharmaceuticals Ltd (Switzerland)","ror":"https://ror.org/05j00sy30","country_code":"CH","type":"company","lineage":["https://openalex.org/I4210136915","https://openalex.org/I4405257665"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"M\u00e9lanie Tunis","raw_affiliation_strings":["Idorsia Pharmaceuticals Ltd., Allschwil, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Idorsia Pharmaceuticals Ltd., Allschwil, Switzerland","institution_ids":["https://openalex.org/I4405257665"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049875519","display_name":"Daniel S. Strasser","orcid":"https://orcid.org/0000-0002-0097-1937","observed_orcids":["https://orcid.org/0000-0002-0097-1937"]},"institutions":[{"id":"https://openalex.org/I4405257665","display_name":"Idorsia Pharmaceuticals Ltd (Switzerland)","ror":"https://ror.org/05j00sy30","country_code":"CH","type":"company","lineage":["https://openalex.org/I4210136915","https://openalex.org/I4405257665"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Daniel S. Strasser","raw_affiliation_strings":["Idorsia Pharmaceuticals Ltd., Allschwil, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Idorsia Pharmaceuticals Ltd., Allschwil, Switzerland","institution_ids":["https://openalex.org/I4405257665"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085220366","display_name":"Fran\u00e7ois Lehembre","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405257665","display_name":"Idorsia Pharmaceuticals Ltd (Switzerland)","ror":"https://ror.org/05j00sy30","country_code":"CH","type":"company","lineage":["https://openalex.org/I4210136915","https://openalex.org/I4405257665"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Fran\u00e7ois Lehembre","raw_affiliation_strings":["Idorsia Pharmaceuticals Ltd., Allschwil, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Idorsia Pharmaceuticals Ltd., Allschwil, Switzerland","institution_ids":["https://openalex.org/I4405257665"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5081955261","display_name":"Marianne M. A. Martinic","orcid":"https://orcid.org/0000-0003-4407-3423","observed_orcids":["https://orcid.org/0000-0003-4407-3423"]},"institutions":[{"id":"https://openalex.org/I4405257665","display_name":"Idorsia Pharmaceuticals Ltd (Switzerland)","ror":"https://ror.org/05j00sy30","country_code":"CH","type":"company","lineage":["https://openalex.org/I4210136915","https://openalex.org/I4405257665"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Marianne M. Martinic","raw_affiliation_strings":["Idorsia Pharmaceuticals Ltd., Allschwil, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Idorsia Pharmaceuticals Ltd., Allschwil, Switzerland","institution_ids":["https://openalex.org/I4405257665"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5007988649"],"corresponding_institution_ids":["https://openalex.org/I4405257665"],"apc_list":{"value":2950,"currency":"USD","value_usd":2950},"apc_paid":{"value":2950,"currency":"USD","value_usd":2950},"fwci":2.4009,"has_fulltext":true,"cited_by_count":27,"citation_normalized_percentile":{"value":0.92466635,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":95,"max":99},"biblio":{"volume":"12","issue":null,"first_page":"748740","last_page":"748740"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11532","display_name":"Chemokine receptors and signaling","score":0.9639000296592712,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11532","display_name":"Chemokine receptors and signaling","score":0.9639000296592712,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10322","display_name":"Respiratory Support and Mechanisms","score":0.028999999165534973,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T14165","display_name":"Inflammation biomarkers and pathways","score":0.0020000000949949026,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ackr3","display_name":"CXCR7","score":0.8420000076293945},{"id":"https://openalex.org/keywords/acute-lung-injury","display_name":"acute lung injury","score":0.9129999876022339},{"id":"https://openalex.org/keywords/acute-respiratory-distress-syndrome","display_name":"acute respiratory distress syndrome","score":0.9990000128746033},{"id":"https://openalex.org/keywords/cxcr3","display_name":"CXCR3","score":0.746999979019165},{"id":"https://openalex.org/keywords/cxcr4","display_name":"CXCR4","score":1.0},{"id":"https://openalex.org/keywords/cxcl11","display_name":"CXCL11","score":0.9679999947547913},{"id":"https://openalex.org/keywords/cxcl12","display_name":"CXCL12","score":1.0},{"id":"https://openalex.org/keywords/pulmonary-inflammation","display_name":"lung inflammation","score":0.6759999990463257},{"id":"https://openalex.org/keywords/neutrophil-infiltration","display_name":"neutrophil infiltration","score":0.8330000042915344},{"id":"https://openalex.org/keywords/alveolar-capillary-barrier-permeability","display_name":"alveolar-capillary barrier permeability","score":0.8709999918937683},{"id":"https://openalex.org/keywords/immune-cell-trafficking","display_name":"immune cell trafficking","score":0.746999979019165}],"concepts":[{"id":"https://openalex.org/C2777383412","wikidata":"https://www.wikidata.org/wiki/Q4770891","display_name":"Antagonism","level":3,"score":0.8524788618087769},{"id":"https://openalex.org/C2780942790","wikidata":"https://www.wikidata.org/wiki/Q372016","display_name":"Pathogenesis","level":2,"score":0.8058226704597473},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5986117124557495},{"id":"https://openalex.org/C2777714996","wikidata":"https://www.wikidata.org/wiki/Q7886","display_name":"Lung","level":2,"score":0.45676541328430176},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.45531851053237915},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.32241392135620117},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.26905637979507446},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.24683019518852234},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.14491304755210876},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.12034940719604492}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.3389/fphar.2021.748740","doi":"https://doi.org/10.3389/fphar.2021.748740","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fphar.2021.748740","pdf_url":null,"source":{"id":"https://openalex.org/S132108250","display_name":"Frontiers in Pharmacology","issn_l":"1663-9812","issn":["1663-9812"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Pharmacology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:8602191","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC8602191/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC8602191/pdf/","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Front Pharmacol","raw_type":"Text"},{"id":"pmid:34803691","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/34803691","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in pharmacology","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:87143f960dcd406b842cdbeee31d0c1a","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/87143f960dcd406b842cdbeee31d0c1a","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Pharmacology, Vol 12 (2021)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3389/fphar.2021.748740","doi":"https://doi.org/10.3389/fphar.2021.748740","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fphar.2021.748740","pdf_url":null,"source":{"id":"https://openalex.org/S132108250","display_name":"Frontiers in Pharmacology","issn_l":"1663-9812","issn":["1663-9812"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Pharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320329429","display_name":"Idorsia Pharmaceuticals","ror":"https://ror.org/03va9ng43"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3211348587.pdf","grobid_xml":"https://content.openalex.org/works/W3211348587.grobid-xml"},"referenced_works_count":58,"referenced_works":["https://openalex.org/W1540508935","https://openalex.org/W1887774545","https://openalex.org/W1966268633","https://openalex.org/W1977091420","https://openalex.org/W1985919362","https://openalex.org/W2004920288","https://openalex.org/W2006303725","https://openalex.org/W2009253992","https://openalex.org/W2010364386","https://openalex.org/W2030490621","https://openalex.org/W2036568786","https://openalex.org/W2043488925","https://openalex.org/W2056452560","https://openalex.org/W2079107760","https://openalex.org/W2079755463","https://openalex.org/W2093852073","https://openalex.org/W2106398910","https://openalex.org/W2115144902","https://openalex.org/W2120094753","https://openalex.org/W2120200154","https://openalex.org/W2123197974","https://openalex.org/W2123699575","https://openalex.org/W2123792735","https://openalex.org/W2135172086","https://openalex.org/W2142320038","https://openalex.org/W2142656747","https://openalex.org/W2143920564","https://openalex.org/W2145610758","https://openalex.org/W2147064547","https://openalex.org/W2147167936","https://openalex.org/W2147346549","https://openalex.org/W2147856180","https://openalex.org/W2153231621","https://openalex.org/W2155705367","https://openalex.org/W2161632137","https://openalex.org/W2162588556","https://openalex.org/W2165730964","https://openalex.org/W2286228001","https://openalex.org/W2593348339","https://openalex.org/W2620107866","https://openalex.org/W2760171305","https://openalex.org/W2767246645","https://openalex.org/W2774703216","https://openalex.org/W2807942155","https://openalex.org/W2943671747","https://openalex.org/W2947328174","https://openalex.org/W3004624574","https://openalex.org/W3024643080","https://openalex.org/W3025231740","https://openalex.org/W3036026378","https://openalex.org/W3041557654","https://openalex.org/W3083122436","https://openalex.org/W3113257652","https://openalex.org/W3131131338","https://openalex.org/W3176659075","https://openalex.org/W4294658238","https://openalex.org/W6652546563","https://openalex.org/W6788258643"],"related_works":["https://openalex.org/W2189270880","https://openalex.org/W2593348339","https://openalex.org/W2010122337","https://openalex.org/W2164673866","https://openalex.org/W2038510554","https://openalex.org/W2153442948","https://openalex.org/W2340293463","https://openalex.org/W3030493277","https://openalex.org/W7098110847","https://openalex.org/W2401757463"],"abstract_inverted_index":{"Loss":[0],"of":[1,6,18,83,91,102,106,141,144,156,190,198,235,244],"control":[2],"in":[3,87,96,99,112,160,167,237,246],"the":[4,10,16,55,80,84,100,113,127,139,142,161,183,187,205,241],"trafficking":[5],"immune":[7,123,179],"cells":[8],"to":[9,15,44,78],"inflamed":[11,168],"lung":[12,21,118,169,191,218],"tissue":[13],"contributes":[14],"pathogenesis":[17],"life-threatening":[19],"acute":[20,29],"injury":[22],"(ALI)":[23],"and":[24,51,60,67,117,133,137,158,171,176,212,221,239],"its":[25,49,52],"more":[26],"severe":[27],"form,":[28],"respiratory":[30],"distress":[31],"syndrome":[32],"(ARDS).":[33],"Targeting":[34],"CXCR7":[35,151,236],"has":[36],"been":[37],"proposed":[38],"as":[39],"a":[40,88,195,231],"potential":[41,243],"therapeutic":[42,213],"approach":[43],"reduce":[45],"pulmonary":[46],"inflammation;":[47],"however,":[48],"role":[50,82,234],"crosstalk":[53],"with":[54,201,215],"two":[56,146],"chemokine":[57,147],"receptors":[58],"CXCR3":[59,131,174],"CXCR4":[61,134,177],"via":[62],"their":[63,165],"shared":[64],"ligands":[65,143],"CXCL11":[66,157],"CXCL12":[68,159],"is":[69],"not":[70],"yet":[71],"completely":[72],"understood.":[73],"The":[74,149],"present":[75],"paper":[76],"aimed":[77],"characterize":[79],"pathological":[81,233],"CXCR3/CXCR4/CXCR7":[85],"axis":[86],"murine":[89],"model":[90],"ALI.":[92],"Lipopolysaccharide":[93],"(LPS)":[94],"inhalation":[95,121],"mice":[97],"resulted":[98],"development":[101],"key":[103,232],"pathologic":[104],"features":[105],"ALI/ARDS,":[107],"including":[108,130],"breathing":[109,207],"dysfunctions,":[110],"alteration":[111],"alveolar":[114],"capillary":[115],"barrier,":[116],"inflammation.":[119],"LPS":[120],"induced":[122],"cell":[124,180,224],"infiltration":[125],"into":[126,182],"bronchoalveolar":[128,184],"space,":[129],"+":[132,135,175,178],"cells,":[136],"enhanced":[138],"expression":[140],"these":[145,228],"receptors.":[148],"first-in-class":[150],"antagonist,":[152],"ACT-1004-1239,":[153],"increased":[154],"levels":[155,166],"plasma":[162],"without":[163],"affecting":[164],"tissue,":[170],"consequently":[172],"reduced":[173,204,217],"infiltrates":[181],"space.":[185],"In":[186,226],"early":[188],"phase":[189],"inflammation,":[192],"characterized":[193],"by":[194],"massive":[196],"influx":[197],"neutrophils,":[199],"treatment":[200,214],"ACT-1004-1239":[202,216,245],"significantly":[203],"LPS-induced":[206],"pattern":[208],"alteration.":[209],"Both":[210],"preventive":[211],"vascular":[219],"permeability":[220],"decreased":[222],"inflammatory":[223],"infiltrates.":[225],"conclusion,":[227],"results":[229],"demonstrate":[230],"ALI/ARDS":[238,247],"highlight":[240],"clinical":[242],"pathogenesis.":[248]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":7},{"year":2022,"cited_by_count":10}],"updated_date":"2026-11-11T12:16:26.678958","created_date":"2021-11-22T00:00:00"}